Usefulness and Limitations of Sequential Serum Tryptase for the Diagnosis of Anaphylaxis in 102 Patients

International Archives of Allergy and Immunology - Tập 160 Số 2 - Trang 192-199 - 2013
Anna Sala1, Victória Cardona, Moisés Labrador‐Horrillo, Olga Luengo, Olga Esteso, Teresa Garriga, María Vicario, Mar Guilarte
1Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Tóm tắt

Background: The diagnosis of anaphylaxis is based on clinical history since no reliable biological marker is currently available to confirm the diagnosis. Objective: It was the aim of this study to determine sequential serum tryptase concentrations during anaphylaxis and to evaluate its potential as a diagnostic marker. Methods: We performed a prospective study including patients with acute anaphylaxis (according to the National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network criteria) attending the emergency department. Demographic characteristics, anaphylactic triggers, specific risk factors, clinical characteristics and management of anaphylaxis were recorded. Serum tryptase was measured at 1–2 h (T1), 4–6 h (T2) and 12–24 h (T3) following onset of the episode and at basal conditions (TB). Results: A total of 102 patients were included (63 females, mean age 47.4 ± 19.1 years). Tryptase concentration at T1 (19.3 ± 15.4 µg/l) was significantly higher than at T2, T3 and TB (all <11.4 µg/l; p < 0.0001). Importantly, tryptase was not raised in 36.3% of cases; furthermore, in 60.6% of these patients, no changes were observed in tryptase levels comparing T1 and TB (ΔT1–TB = 0). Tryptase was more frequently elevated in more severe anaphylaxis (p < 0.0001) and positively correlated with the grades of severity (p < 0.001, r = 0.49). Anaphylaxis was more severe and tryptase concentration higher when the causative agent was a drug compared to food, both at T1 (p = 0.045) and at TB (p = 0.019). Age and coronary risk factors were associated with more severe anaphylaxis (p = 0.001). Conclusion: Tryptase is a biomarker related to the severity of anaphylaxis. However, since its concentration remains unaltered in a considerable number of patients during acute anaphylaxis, there is a need for more reliable diagnostic biological tests.

Từ khóa


Tài liệu tham khảo

10.1016%2Fj.jaci.2005.12.1303

10.1111%2Fj.1398-9995.2011.02629.x

10.1111%2Fj.1365-2222.2011.03779.x

10.1006%2Fmeth.1997.0494

10.1016%2Fj.jaci.2007.05.001

10.1056%2FNEJM199208063270603

10.1016%2Fj.iac.2006.05.010

10.1172%2FJCI114051

10.1016%2Fj.jaci.2004.04.029

10.1016%2Fj.jaci.2009.12.981

10.1016%2Fj.jaci.2011.01.038

10.1016%2Fj.jaci.2009.07.055

10.1111%2Fj.1365-2222.2011.03893.x

10.1067%2Fmai.2000.107600

10.1097%2F00000542-199112000-00004

10.1111%2Fj.1365-2222.1996.tb00540.x

10.1056%2FNEJM195908202610803

10.3109%2F02770906609106941

10.1016%2FS0091-6749%2805%2980012-0

10.1016%2FS0091-6749%2898%2970239-8

10.1001%2Farchinte.155.16.1749

10.1067%2Fmai.2001.119028

10.1016%2Fj.jemermed.2004.11.028

10.1016%2Fj.jaci.2009.08.025

10.1111%2Fj.1365-2249.2008.03714.x

10.1097%2FACI.0b013e328259c328

10.1016%2FS1081-1206%2810%2960714-4

10.1007%2Fs11882-008-0008-8

10.1016%2Fj.jaci.2009.08.027

10.1016%2Fj.jaci.2011.09.030

Thông tin
Thông tin xuất bản

International Archives of Allergy and Immunology

Tập 160 Số 2

192-199

Thông tin tác giả